Skip to main content
SpringerLink
Log in

Future Therapies for Trigeminal Autonomic Cephalalgias: Cluster Headache and Related Conditions

  • Chapter
  • First Online:
Cluster Headache and other Trigeminal Autonomic Cephalgias

Part of the book series: Headache ((HEAD))

  • 775 Accesses

Abstract

The trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders linked by usually prominent cranial autonomic features [1] that when present are typically lateralized to the side of the pain [2]. The TACs are grouped under section 3 of the current International Classification of Headache Disorders-3 [3]. They consist of cluster headache [4], paroxysmal hemicrania [5], short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)/cranial autonomic feature (SUNA) [6] and hemicrania continua [7]. These are devastating problems with patients describing the pain of cluster headache as the worst they have ever experienced [8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain. 1997;120:193–209.

    PubMed  Google Scholar 

  2. Nesbitt AD, Goadsby PJ. Cluster Headache. Br Med J. 2012;344:e2407.

    Article  Google Scholar 

  3. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cepahalalgia. 2018;38:1–211.

    Google Scholar 

  4. Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol. 2018;17(1):75–83.

    Article  PubMed  Google Scholar 

  5. Cittadini E, Matharu MS, Goadsby PJ. Paroxysmal hemicrania: a prospective clinical study of thirty-one cases. Brain. 2008;131:1142–55.

    Article  PubMed  Google Scholar 

  6. Cohen AS, Matharu MS, Goadsby PJ. Short-lasting Unilateral neuralgiform Headache Attacks with conjunctival injection and Tearing (SUNCT) or cranial Autonomic features (SUNA). A prospective clinical study of SUNCT and SUNA. Brain. 2006;129:2746–60.

    Article  PubMed  Google Scholar 

  7. Cittadini E, Goadsby PJ. Hemicrania continua: a clinical study of 39 patients with diagnostic implications. Brain. 2010;133:1973–86.

    Article  PubMed  Google Scholar 

  8. Schor LI. Cluster headache: investigating severity of pain, suicidality, personal burden, access to effective treatment, and demographics among a large International survey sample. Cephalalgia. 2017;37(1S):172.

    Google Scholar 

  9. Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, MaassenVanDenBrink A, et al. Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine. Headache. 2004;44:414–25.

    Article  PubMed  Google Scholar 

  10. Cohen AS, Burns B, Goadsby PJ. High flow oxygen for treatment of cluster headache. A randomized trial. J Am Med Assoc. 2009;302:2451–7.

    Article  CAS  Google Scholar 

  11. Petersen AS, Barloese MC, Lund NL, Jensen RH. Oxygen therapy for cluster headache. A mask comparison trial. A single-blinded, placebo-controlled, crossover study. Cephalalgia. 2017;37:214–24.

    Article  PubMed  Google Scholar 

  12. Dixon R, Gillotin C, Gibbens M, Posner J, Peck RW. The pharmacokinetics and effects on blood pressure of multiple doses of the novel antimigraine drug zolmitriptan (311C90) in healthy volunteers. Br J Clin Pharmacol. 1997;43:273–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Gregor N, Schlesiger C, Akova-Ozturk E, Kraemer C, Husstedt IW, Evers S. Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan. Headache. 2005;45(8):1069–72.

    Article  PubMed  Google Scholar 

  14. Silberstein SD, Mechtler LL, Kudrow DB, Calhoun AH, McClure C, Saper JR, et al. Non-invasive vagus nerve stimulation for the Acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study. Headache. 2016;56:1317–32.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Goadsby PJ, de Coo IF, Silver N, Tyagi A, Ahmed F, Gaul C, et al. Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: a randomized, double-blind, sham-controlled ACT2 study. Cephalalgia. 2018;38:959–69.

    Article  PubMed  Google Scholar 

  16. Nesbitt AD, Marin JCA, Tompkins E, Ruttledge MH, Goadsby PJ. Initial experience with a novel non-invasive vagus nerve stimulation device for the treatment of cluster headache. Neurology (Minneap). 2015;84:1–5.

    Article  Google Scholar 

  17. de Coo IF, Marin J, Silberstein SD, Friedman DI, Gaul C, Tyagi A, et al. Non-invasive vagus nerve stimulation for acute treatment of episodic and chronic cluster headache: pooled analysis of data from two randomised, double-blind, sham-controlled clinical trials. Cephalalgia. 2017;37(1S):175–6.

    Google Scholar 

  18. Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache- randomized placebo-controlled double-blind cross-over study. Ann Neurol. 2004;56:488–94.

    Article  CAS  PubMed  Google Scholar 

  19. McKeage K. Pasireotide in acromegaly: a review. Drugs. 2015;75(9):1039–48.

    Article  CAS  PubMed  Google Scholar 

  20. Lesche S, Lehmann D, Nagel F, Schmid HA, Schulz S. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. J Clin Endocrinol Metab. 2009;94(2):654–61.

    Article  CAS  PubMed  Google Scholar 

  21. Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118:92–6.

    Article  CAS  PubMed  Google Scholar 

  22. Leroux E, Valade D, Taifas I, Vicaut E, Chagnon M, Roos C, et al. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2011;10:891–7.

    Article  CAS  PubMed  Google Scholar 

  23. Jammes JL. The treatment of cluster headaches with prednisone. Dis Nerv Syst. 1975;36:375–6.

    CAS  PubMed  Google Scholar 

  24. Mirzai R, Chang C, Greenspan A, Gershwin ME. The pathogenesis of osteonecrosis and the relationships to corticosteroids. J Asthma. 1999;36:77–95.

    Article  CAS  PubMed  Google Scholar 

  25. Symonds C. A particular variety of headache. Brain. 1956;79:217–32.

    Article  CAS  PubMed  Google Scholar 

  26. Gaul C, Jurgens T. Frovatriptan for prophylactic treatment of cluster headache. Headache. 2011;51:1008–9.

    Article  PubMed  Google Scholar 

  27. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Brain. 1994;117:427–34.

    Article  PubMed  Google Scholar 

  28. Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S. Increase in plasma calcitonin gene-related peptide from extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain. 1995;60:119–23.

    Article  CAS  PubMed  Google Scholar 

  29. Ong JJY, Wei DY, Goadsby PJ. Recent advances in pharmacotherapy for migraine prevention: from pathophysiology to new drugs. Drugs. 2018;78:411–37.

    Article  CAS  PubMed  Google Scholar 

  30. Oakes TMM, Skljarevski V, Zhang Q, Kielbasa W, Hodsdon ME, Detke HC, et al. Safety of galcanezumab in patients with episodic migraine: a randomized placebo-controlled dose-ranging Phase 2b study. Cephalalgia. 2018;38(6):1015–25.

    Article  PubMed  Google Scholar 

  31. Martinez JM, Goadsby PJ, Dodick DW, Bardos JN, Oakes TMM, Millen BA, et al. A placebo-controlled study of galcanezumab in patients with episodic cluster headache: from the 8-week double-blind treatment phase. Headache. 2018;58:1289–90.

    Google Scholar 

  32. Dodick DW, Goadsby PJ, Spierings ELH, Scherer JC, Sweeney SP, Grayzel DS. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study. Lancet Neurol. 2014;13:885–92.

    Article  CAS  PubMed  Google Scholar 

  33. Skljarevski V, Matharu M, Millen BA, Ossipov MH, Kim BK, Yang JY. Efficacy and safety of galcanezumab for the prevention of episodic migraine: results of the EVOLVE-2 phase 3 randomized controlled clinical trial. Cephalalgia. 2018;38:1442–54. https://doi.org/10.1177/0333102418779543.

    Article  PubMed  Google Scholar 

  34. Skljarevski V, Oakes TM, Zhang Q, Ferguson MB, Martinez J, Camporeale A, et al. Galcanezumab for episodic migraine prevention: a randomized phase 2b placebo-controlled dose-ranging clinical trial. JAMA Neurol. 2018;75:187–93.

    Article  PubMed  Google Scholar 

  35. Stauffer VL, Dodick DW, Zhang Q, Carter JN, Ailani J, Conley RR. Evaluation of galcanezumab for the prevention of episodic migraine: The EVOLVE-1 Randomized Clinical Trial. JAMA Neurol. 2018;75:1080–8.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Dodick DW, Silberstein SD, Bigal ME, Yeung P, Goadsby PJ, Blankenbiller T, et al. Effect of fremanezumab compared with placebo on the prevention of episodic migraine: a randomized clinical trial. JAMA Neurol. 2018;319:1999–2008.

    Article  CAS  Google Scholar 

  37. Silberstein SD, Aycardi E, Bigal ME, Blankenbiller T, Dodick DW, Goadsby PJ, et al. Fremanezumab for chonic migraine preventive treatment. N Engl J Med. 2017;377:2113–22.

    Article  CAS  PubMed  Google Scholar 

  38. Goadsby PJ, Schoenen J, Ferrari MD, Silberstein SD, Dodick D. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia. 2006;26:1168–70.

    Article  CAS  PubMed  Google Scholar 

  39. Leone M, Franzini A, Broggi G, Dodick D, Rapoport A, Goadsby PJ, et al. Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia. 2004;24:934–7.

    Article  CAS  PubMed  Google Scholar 

  40. Mathew NT, Hurt W. Percutaneous radiofrequency trigeminal gangliorhizolysis in intractable cluster headache. Headache. 1988;28:328–31.

    Article  CAS  PubMed  Google Scholar 

  41. Donnet A, Valade D, Regis J. Gamma knife treatment for refractory cluster headache: prospective open trial. J Neurol Neurosurg Psychiatry. 2005;76:218–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Filippini-De Moor GPG, Barendse GAM, van Kleef M, Troost J, de Lange S, Sluijter ME, et al. Retrospective analysis of radiofrequency lesions of the sphenopalatine ganglion in the treatment of 19 cluster headache patients. Pain Clin. 1999;11:285–91.

    Google Scholar 

  43. Narouze S, Kapural L, Casanova J, Mekhail N. Sphenopalatine ganglion radiofrequency ablation for the management of chronic cluster headache. Headache. 2009;49:571–7.

    Article  PubMed  Google Scholar 

  44. Jarrar RG, Black DF, Dodick DW, Davis DH. Outcome of trigeminal nerve section in the treatment of chronic cluster headache. Neurology. 2003;60:1360–2.

    Article  CAS  PubMed  Google Scholar 

  45. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352:275–8.

    Article  CAS  PubMed  Google Scholar 

  46. Leone M, Franzini A, Bussone G. Stereotatic stimulation of the posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med. 2001;345:1428–9.

    Article  CAS  PubMed  Google Scholar 

  47. Leone M, Franzini A, Cecchini AP, Broggi G, Bussone G. Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. Ther Adv Neurol Disord. 2010;3(3):187–95.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Schoenen J, Di Clemente L, Vandenheede M, Fumal A, De Pasqua V, Mouchamps M, et al. Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain. 2005;128:940–7.

    Article  CAS  PubMed  Google Scholar 

  49. Fontaine D, Lazorthes Y, Mertens P, Blond S, Geraud G, Fabre N, et al. Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. J Headache Pain. 2010;11:23–31.

    Article  CAS  PubMed  Google Scholar 

  50. Burns B, Watkins L, Goadsby PJ. Successful treatment of medically intractable cluster headache using occipital nerve stimulation (ONS). Lancet. 2007;369:1099–106.

    Article  PubMed  Google Scholar 

  51. Magis D, Allena M, Bolla M, De Pasqua V, Remacle JM, Schoenen J. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol. 2007;6:314–21.

    Article  PubMed  Google Scholar 

  52. Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology. 2009;72:341–5.

    Article  CAS  PubMed  Google Scholar 

  53. Gray H. Anatomy of the human body. Philadelphia: Lea & Febiger; 1918.. www.bartleby.com/107/

    Book  Google Scholar 

  54. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiological implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab. 1999;19:115–27.

    Article  CAS  PubMed  Google Scholar 

  55. Goadsby PJ, Lambert GA, Lance JW. The peripheral pathway for extracranial vasodilatation in the cat. J Auton Nerv Syst. 1984;10:145–55.

    Article  CAS  PubMed  Google Scholar 

  56. Sluder G. The role of the sphenopalatine (or Meckle’s) ganglion in nasal headaches. NY Med J. 1908;87:989–90.

    Google Scholar 

  57. Ansarinia M, Rezai A, Tepper SJ, Steiner CP, Stump J, Stanton-Hicks M, et al. Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches. Headache. 2010;50(7):1164–74.

    Article  PubMed  Google Scholar 

  58. Schoenen J, Jensen RH, Lanteri-Minet M, Lainez JM, Gaul C, Goodman AM, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia. 2013;33:816–30.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Goadsby PJ, Sahai-Srivastava S, Kezirian EJ, Calhoun AH, Matthews DC, McAllister PJ, et al. Sham-controlled study of sphenopalatine ganglion stimulation for chronic cluster headache. Headache. 2018;58:1316–7.

    Google Scholar 

  60. Jurgens TP, Barloese M, May A, Lainez JM, Schoenen J, Gaul C, et al. Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache. Cephalalgia. 2017;37:423–34.

    Article  PubMed  Google Scholar 

  61. Tso AR, Marin JCA, Goadsby PJ. Non-invasive vagus nerve stimulation for treatment of indomethacin-sensitive headaches. JAMA Neurol. 2017;74:1266–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. NIHR-Wellcome Trust King’s Clinical Research Facility & SLaM Biomedical Research Centre, King’s College London, London, UK

    Peter J. Goadsby

  2. Department of Internal Medicine, University of Lund, Lund, Sweden

    Lars Edvinsson

Authors
  1. Peter J. Goadsby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lars Edvinsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter J. Goadsby .

Editor information

Editors and Affiliations

  1. Department of Neurology, Neuroalgology Unit, The Foundation of the Carlo Besta Neurological Institute, IRCCS, Milano, Italy

    Massimo Leone

  2. Department of Systems Neuroscience, University of Hamburg, Hamburg, Germany

    Arne May

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goadsby, P.J., Edvinsson, L. (2020). Future Therapies for Trigeminal Autonomic Cephalalgias: Cluster Headache and Related Conditions. In: Leone, M., May, A. (eds) Cluster Headache and other Trigeminal Autonomic Cephalgias. Headache. Springer, Cham. https://doi.org/10.1007/978-3-030-12438-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-12438-0_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-12437-3

  • Online ISBN: 978-3-030-12438-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation